These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 39358446)

  • 1. Analysis and comparison of post-translational modifications of α-synuclein filaments in multiple system atrophy and dementia with Lewy bodies.
    Kametani F; Tahira M; Takao M; Matsubara T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Hasegawa M
    Sci Rep; 2024 Oct; 14(1):22892. PubMed ID: 39358446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
    Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K
    Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of α-synuclein filaments from human brains with Lewy pathology.
    Yang Y; Shi Y; Schweighauser M; Zhang X; Kotecha A; Murzin AG; Garringer HJ; Cullinane PW; Saito Y; Foroud T; Warner TT; Hasegawa K; Vidal R; Murayama S; Revesz T; Ghetti B; Hasegawa M; Lashley T; Scheres SHW; Goedert M
    Nature; 2022 Oct; 610(7933):791-795. PubMed ID: 36108674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of α-synuclein filaments from multiple system atrophy.
    Schweighauser M; Shi Y; Tarutani A; Kametani F; Murzin AG; Ghetti B; Matsubara T; Tomita T; Ando T; Hasegawa K; Murayama S; Yoshida M; Hasegawa M; Scheres SHW; Goedert M
    Nature; 2020 Sep; 585(7825):464-469. PubMed ID: 32461689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy.
    Lövestam S; Schweighauser M; Matsubara T; Murayama S; Tomita T; Ando T; Hasegawa K; Yoshida M; Tarutani A; Hasegawa M; Goedert M; Scheres SHW
    FEBS Open Bio; 2021 Apr; 11(4):999-1013. PubMed ID: 33548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
    Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
    Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
    Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rostral raphe involvement in Lewy body dementia and multiple system atrophy.
    Benarroch EE; Schmeichel AM; Sandroni P; Parisi JE; Low PA
    Acta Neuropathol; 2007 Sep; 114(3):213-20. PubMed ID: 17639427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.
    Altay MF; Liu AKL; Holton JL; Parkkinen L; Lashuel HA
    Acta Neuropathol Commun; 2022 Nov; 10(1):163. PubMed ID: 36371251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia.
    Benarroch EE; Schmeichel AM; Dugger BN; Sandroni P; Parisi JE; Low PA
    Neurology; 2009 Jul; 73(2):106-12. PubMed ID: 19597132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
    Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
    Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies.
    Hass EW; Sorrentino ZA; Xia Y; Lloyd GM; Trojanowski JQ; Prokop S; Giasson BI
    Acta Neuropathol Commun; 2021 Aug; 9(1):146. PubMed ID: 34454615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degeneration of brainstem respiratory neurons in dementia with Lewy bodies.
    Presti MF; Schmeichel AM; Low PA; Parisi JE; Benarroch EE
    Sleep; 2014 Feb; 37(2):373-8. PubMed ID: 24501436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.
    Anderson JP; Walker DE; Goldstein JM; de Laat R; Banducci K; Caccavello RJ; Barbour R; Huang J; Kling K; Lee M; Diep L; Keim PS; Shen X; Chataway T; Schlossmacher MG; Seubert P; Schenk D; Sinha S; Gai WP; Chilcote TJ
    J Biol Chem; 2006 Oct; 281(40):29739-52. PubMed ID: 16847063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.